Literature DB >> 21741925

Mutation in the mitochondrial translation elongation factor EFTs results in severe infantile liver failure.

Vanessa Vedrenne1, Louise Galmiche, Dominique Chretien, Pascale de Lonlay, Arnold Munnich, Agnès Rötig.   

Abstract

BACKGROUND & AIMS: Multiple respiratory chain deficiencies represent a common cause of mitochondrial diseases and often result in hepatic failure. A significant fraction of patients present mitochondrial DNA depletion but a number of cases remain unexplained. The aim of our study was to identify the disease causing gene in a kindred with intrauterine growth retardation, neonatal lactic acidosis, liver dysfunction and multiple respiratory chain deficiency in muscle.
METHODS: Homozygosity mapping was performed by 50K SNP genotyping and candidate genes were successively analyzed by direct sequencing on genomic DNA of the family members.
RESULTS: SNP genotyping detected several regions of homozygosity in which we focused our attention to genes involved in mitochondrial translation. We sequenced the TSFM gene, encoding the mitochondrial translation factor EFTs and identified a homozygous mutation changing a highly conserved arginine into a tryptophan (R312W).
CONCLUSIONS: This mutation has been previously reported in two unrelated kindred presenting two distinct syndromes (fatal mitochondrial encephalomyopathy and hypertrophic cardiomyopathy respectively). The description of a third syndrome associated with a same TSFM mutation gives support to the broad clinical and genetic heterogeneity of mitochondrial translation deficiencies in human. It suggests that mitochondrial translation deficiency represents a growing cause of hepatic failure of mitochondrial origin in infants.
Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21741925     DOI: 10.1016/j.jhep.2011.06.014

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  19 in total

1.  Novel homozygous TSFM pathogenic variant associated with encephalocardiomyopathy with sensorineural hearing loss and peculiar neuroradiologic findings.

Authors:  Marcello Scala; Giorgia Brigati; Chiara Fiorillo; Claudia Nesti; Anna Rubegni; Marina Pedemonte; Claudio Bruno; Mariasavina Severino; Maria Derchi; Carlo Minetti; F M Santorelli
Journal:  Neurogenetics       Date:  2019-07-02       Impact factor: 2.660

2.  Molecular-genetic characterization and rescue of a TSFM mutation causing childhood-onset ataxia and nonobstructive cardiomyopathy.

Authors:  Sonia Emperador; M Pilar Bayona-Bafaluy; Ana Fernández-Marmiesse; Mercedes Pineda; Blanca Felgueroso; Ester López-Gallardo; Rafael Artuch; Iria Roca; Eduardo Ruiz-Pesini; María Luz Couce; Julio Montoya
Journal:  Eur J Hum Genet       Date:  2016-09-28       Impact factor: 4.246

3.  Mitochondrial disease--an important cause of end-stage renal failure.

Authors:  Shamima Rahman; Andrew M Hall
Journal:  Pediatr Nephrol       Date:  2012-12-12       Impact factor: 3.714

4.  Severe respiratory complex III defect prevents liver adaptation to prolonged fasting.

Authors:  Laura S Kremer; Caroline L'hermitte-Stead; Pierre Lesimple; Mylène Gilleron; Sandrine Filaut; Claude Jardel; Tobias B Haack; Tim M Strom; Thomas Meitinger; Hatem Azzouz; Neji Tebib; Hélène Ogier de Baulny; Guy Touati; Holger Prokisch; Anne Lombès
Journal:  J Hepatol       Date:  2016-05-02       Impact factor: 25.083

5.  Identification of extremely rare mitochondrial disorders by whole exome sequencing.

Authors:  Go Hun Seo; Arum Oh; Eun Na Kim; Yeonmi Lee; Jumi Park; Taeho Kim; Young-Min Lim; Gu-Hwan Kim; Chong Jai Kim; Han-Wook Yoo; Eunju Kang; Beom Hee Lee
Journal:  J Hum Genet       Date:  2019-08-26       Impact factor: 3.172

6.  Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome.

Authors:  Alexander S Hebert; Kristin E Dittenhafer-Reed; Wei Yu; Derek J Bailey; Ebru Selin Selen; Melissa D Boersma; Joshua J Carson; Marco Tonelli; Allison J Balloon; Alan J Higbee; Michael S Westphall; David J Pagliarini; Tomas A Prolla; Fariba Assadi-Porter; Sushmita Roy; John M Denu; Joshua J Coon
Journal:  Mol Cell       Date:  2012-11-29       Impact factor: 17.970

7.  Mitochondrial EFTs defects in juvenile-onset Leigh disease, ataxia, neuropathy, and optic atrophy.

Authors:  Sofia Ahola; Pirjo Isohanni; Liliya Euro; Virginia Brilhante; Aarno Palotie; Helena Pihko; Tuula Lönnqvist; Tanita Lehtonen; Jukka Laine; Henna Tyynismaa; Anu Suomalainen
Journal:  Neurology       Date:  2014-07-18       Impact factor: 9.910

8.  Unusual clinical expression and long survival of a pseudouridylate synthase (PUS1) mutation into adulthood.

Authors:  Metodi D Metodiev; Zahra Assouline; Pierre Landrieu; Dominique Chretien; Brigitte Bader-Meunier; Corinne Guitton; Arnold Munnich; Agnès Rötig
Journal:  Eur J Hum Genet       Date:  2014-09-17       Impact factor: 4.246

Review 9.  Evaluation of the child with suspected mitochondrial liver disease.

Authors:  Jean P Molleston; Ronald J Sokol; Wikrom Karnsakul; Alexander Miethke; Simon Horslen; John C Magee; René Romero; Robert H Squires; Johan L K Van Hove
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-09       Impact factor: 2.839

10.  Infantile encephaloneuromyopathy and defective mitochondrial translation are due to a homozygous RMND1 mutation.

Authors:  Beatriz Garcia-Diaz; Mario H Barros; Simone Sanna-Cherchi; Valentina Emmanuele; Hasan O Akman; Claudia C Ferreiro-Barros; Rita Horvath; Saba Tadesse; Nader El Gharaby; Salvatore DiMauro; Darryl C De Vivo; Aly Shokr; Michio Hirano; Catarina M Quinzii
Journal:  Am J Hum Genet       Date:  2012-09-27       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.